DRIEHAUS CAPITAL MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 82 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$242,000
-6.2%
5,620
-69.5%
0.01%0.0%
Q3 2015$258,000
-89.6%
18,397
-87.4%
0.01%
-89.5%
Q2 2015$2,481,000
+27.8%
146,135
-9.0%
0.09%
+28.4%
Q1 2015$1,941,000
+218.7%
160,511
+135.5%
0.07%
+252.6%
Q1 2014$609,00068,1490.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders